Иммунологические механизмы эффекторного звена системы иммунитета при аллотрансплантации
Аннотация
Авторы описывают молекулярные и клеточные процессы, сопровождающие эффекторное звено иммунного ответа при трансплантации органов. С учетом различных исследовательских работ приводятся значимые патогенетические аспекты клеточного и гуморального механизмов повреждения трансплантата, особенности формирования иммунологической толерантности и возможности применения результатов исследований в развитии подходов к иммуносупрессивной терапии.
Об авторах
С. В. Зыблева
ГУ «РНПЦ радиационной медицины и экологии человека», г. Гомель, Беларусь
Россия
Россия
С. Л. Зыблев
ГУ «РНПЦ радиационной медицины и экологии человека», г. Гомель, Беларусь
Россия
Россия
Список литературы
1. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells / D. Amsen [et al.] // Cell. - 2004. - Vol. 117. - P. 515-526.
2. Immune privilege induced by regulatory T cells in transplantation tolerance / S.P. Cobbold [et al.] // Immunol Rev. - 2006. - Vol. 213. - P. 239-255.
3. Colvin, R.B. Antibody-mediated organ-allograft rejection / R.B. Colvin, R.N. Smith // Nat Rev Immunol. - 2005. - Vol. 5. - P. 807-817.
4. Notch: control of lymphocyte differentiation in the periphery / M.J. Dallman [et al.] // Curr Opin Immunol. - 2005. - Vol. 17. - P. 259-266.
5. Delikouras, A. Transplant accommodation / A. Delikouras, A. Dorling // Am J Transplant. - 2003. - Vol. 3. - P. 917-918.
6. Endothelial cell cyto-protection induced in vitro by allo- or xenoreactive antibodies is mediated by signaling through adenosine A2 receptors / A. Delikouras [et al.] // Eur J Immunol. - 2003. - Vol. 33. - P. 3127- 3135.
7. Gaiano, N. The role of Notch in promoting glial and neural stem cell fates / N. Gaiano, G. Fishell // Annu Rev Neurosci. - 2002. - Vol. 25. - P. 471-490.
8. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection / W. Gao [et al.] // J Clin Invest. - 2000. - Vol. 105. - P. 35-44.
9. Endothelial cells as targets of allograft rejection / D. Glotz [et al.] // Transplantation. - 2006. - Vol. 82, № 1. - P. 19-21.
10. Donor-derived IP-10 initiates development of acute allograft rejection / W.W. Hancock [et al.] // J Exp Med. - 2001. - Vol. 193. - P. 975-980.
11. Hancock, W.W. Chemokines and transplant immunobiology / W.W. Hancock // J Am Soc Nephrol. - 2002. - Vol. 13. - P. 821- 824.
12. Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression / W.W. Hancock [et al.] // Curr Opin Immunol. - 2003. - Vol. 15. - P. 479-486.
13. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages / L.E. Harrington [et al.] // Nat Immunol. - 2005. - Vol. 6. - P. 1123-1132.
14. Harrington, L.E. Expanding the effector CD4 T-cell repertoire: the Th17 lineage / L.E. Harrington, P.R. Mangan, C.T. Weaver // Curr Opin Immunol. - 2006. - Vol. 18. - P. 349-356.
15. Antibody, complement and accommodation in ABO-incompatible transplants / K.E. King [et al.] // Curr Opin Immunol. - 2004. - Vol. 16. - P. 545-549.
16. The changing role of natural killer cells in solid organ rejection and tolerance / W.H. Kitchens [et al.] // Transplantation. - 2006. - Vol. 81. - P. 811-817.
17. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation / C.L. Langrish [et al.] // J Exp Med. - 2005. - Vol. 201. - P. 233-240.
18. Molecular and cellular events associated with ischemia/reperfusion injury / I. Laskowski [et al.] // Ann Transplant. - 2000. - Vol. 5. - P. 29-35.
19. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation / S. Le Bas-Bernardet [et al.] // Transplantation. - 2003. - Vol. 75. - P. 477- 482.
20. Antigen recognition influences transendothelial migration of CD4+ T cells / F.M. Marelli-Berg [et al.] // J Immunol. - 1999. - Vol. 162. - P. 696-703.
21. Margaret, J. Dallman Immunology of graft regection /j. Margaret // Kidney Transplantation - Principles and Practice / Peter Morris, Stuart J. Knechtle. - P. 9-32.
22. Mellor, A.L. Immune privilege: a recurrent theme in immunoregulation / A.L. Mellor, D.H. Munn // Immunol Rev. - 2006. - Vol. 213. - P. 5-11.
23. Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction / S. Merani [et al.] // Cell Transplant. - 2006. - Vol. 15. - P. 295-309.
24. Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure / T. Nemoto [et al.] // Kidney Int. - 2001. - Vol. 60. - P. 2205-2214.
25. Niederkorn, J.Y. The immune privilege of corneal allografts /j.Y. Niederkorn // Transplantation. - 1999. - Vol. 67. - P. 1503- 1508.
26. A highly selective inhibitor of Rho-associated coiled-coil forming protein kinase, Y-27632, prolongs cardiac allograft survival of the BALB/c-to-C3H/He mouse model / S. Ohki [et al.] // J Heart Lung Transplant. - 2001. - Vol. 20. - P. 956-963.
27. T helper cell effector fates - who, how and where? / R.L. Reinhardt [et al.] // Curr Opin Immunol. - 2006. - Vol. 18. - P. 271- 277.
28. Tubulitis after renal transplantation: demonstration of an association between CD103+ T cells, transforming growth factor beta1 expression and rejection grade / H. Robertson [et al.] // Transplantation. - 2001. - Vol. 71. - P. 306-313.
29. Rossi, D. The biology of chemokines and their receptors / D. Rossi, A. Zlotnik // Annu Rev Immunol. - 2000. - Vol. 18. - P. 217-242.
30. Sakaguchi, S. Regulatory T cells: key controllers of immunologic self-tolerance / S. Sakaguchi // Cell. - 2000. - Vol. 101. - P. 455-458.
31. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease / S. Sakaguchi [et al.] // Immunol Rev. - 2006. - Vol. 212. - P. 8-27.
32. Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody / A.D. Salama [et al.] // Am J Transplant. - 2001. - Vol. 1. - P. 260-269.
33. Salama, A.D. Drug insight: rituximab in renal disease and transplantation / A.D. Salama, C.D. Pusey // Nat Clin Pract Nephrol. - 2006. - Vol. 2. - P. 221-230.
34. An oral formulation for intra-cellular adhesion molecules-1 antisense oligonucleotides / S.M. Stepkowski [et al.] // Transplant Proc. - 2001. - Vol. 33, № (7-8). - P. 3271.
35. Stepkowski, S.M. Therapeutic potential for adhesion antagonists in organ transplantation / S.M. Stepkowski // Curr Opin Organ Transplant. - 2002. - Vol. 7. - P. 366-372.
36. Attenuation of renal ischemia-reperfusion injury with selectin inhibition in a rabbit model / S. Subramanian [et al.] // Am J Surg. - 1999. - Vol. 178. - P. 573-576.
37. Notch signaling is an important regulator of type 2 immunity / L.Tu [et al.] // J Exp Med. - 2005. - Vol. 202. - P. 1037-1042.
38. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts / S. Uehara [et al.] // J Immunol. - 2005. - Vol. 175. - P. 3424-3430.
39. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells / M. Veldhoen [et al.] // Immunity. - 2006. - Vol. 24. - P. 179-189.
40. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease / M. Veldhoen [et al.] // Nat Immunol. - 2006. - Vol. 7. - P. 1151-1156.
41. Notch ligation by Delta1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism / K.K. Wong [et al.] // J Clin Invest. - 2003. - Vol. 112. - P. 1741-1750.
42. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells / W.K. Wong [et al.] // Transplantation. - 2003. - Vol. 75. - P. 505-514.
43. Therapeutic manipulation of T cell chemotaxis in transplantation / A.C. Yopp [et al.] // Curr Opin Immunol. - 2004. - Vol. 16. - P. 571-577.
Рецензия
Для цитирования:
Зыблева С.В., Зыблев С.Л. Иммунологические механизмы эффекторного звена системы иммунитета при аллотрансплантации. Медико-биологические проблемы жизнедеятельности. 2020;(2):13-24.
For citation:
Zybleva S., Zyblev S. The immunologic mechanism of the immune system effector am in the allotransplantation. Medical and Biological Problems of Life Activity. 2020;(2):13-24. (In Russ.)
Просмотров: 119
Послать статью по эл. почте 